Medicine recalls
|
| |
| Canada: Recall: MAR-Cetirizine 20 mg tablet: Out of specification (Impurities) |
| |
Health Canada announces that Marcan Pharmaceuticals Inc. is recalling one lot of MAR-Cetirizine 20 mg tablet (lot number: H221345) from wholesalers because the impurities are out of specification in the affected lot.
The product is indicated for the fast relief of nasal and non-nasal symptoms associated with seasonal and perennial allergic rhinitis and chronic idiopathic urticaria.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/mar-cetirizine-20-mg-tablet-out-specification-impurities
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by Health Canada, and was posted on the Drug Office website on 10 Nov 2021.
Ends/Friday, Mar 21, 2025
Issued at HKT 15:00
|
| |
|
